When it comes to your cleaning necessities, get ready to shell out some cash for less products.
Proctor & Gamble, the parent company of many of your go-to cleaning supplies like Cascade, Tide, and Swiffer, among others, is set to hike the prices on many of its goods. The company cites inflation and the cost to manufacture its products as the reason behind the increases.
On Thursday, the company reported year-over-year declines in sales, revenue and profits despite raising prices to offset losses. The dropoff was linked to a slip in consumer demand.
In concert with the price hikes, P&G is also set to scale back on its product sizes. Known as shrinkflation, consumers will pay the increased cost while simultaneously receiving less product than they had previously for the item.
Even as demand dwindles for the consumer-goods behemoth, P&G has no plans to lower price in the short-term. In Thursday's earnings call, Andre Schulten, chief financial officer at P&G, said consumers continue to make purchases because the items his company provides are necessities.
"Consumers don't stop washing their hands or doing their laundry," he noted.
Prices are set to increase even more in the coming months. P&G also boosted its 2023 sales outlook to a range between 4 and 5 percent growth.
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
